Goldman Sachs’s Sight Sciences SGHT Stock Holding History
Bought
Maintained
Sold
Other funds holding SGHT
LFCM
AP
BGI
Goldman Sachs's SGHT Position: Q2 2026 in Review
Goldman Sachs increased its Sight Sciences (SGHT) stake by 58% in Q2 2026, buying an estimated $339K and bringing the position to 200,127 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #5148.
Goldman Sachs first reported a position in SGHT in Q3 2021 and has held it in 15 quarters since. The position peaked at $1.71M in Q2 2022. 111 funds tracked by Wall St. Rank hold SGHT as of Q2 2026.
- Goldman Sachs held 200,127 shares of Sight Sciences worth $1.08M as of Q2 2026.
- Goldman Sachs bought 73,737 Sight Sciences shares in Q2 2026, an estimated $339K.
- Sight Sciences made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #5148 holding.
- Goldman Sachs first reported a position in Sight Sciences in Q3 2021 and has held it in 15 quarters since.
- Goldman Sachs's Sight Sciences position peaked at $1.71M in Q2 2022.
- 111 funds tracked by Wall St. Rank held Sight Sciences as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.